The company is moving from a 900-square-foot space to a 2,800-square-foot space. DiFUSION is working to commercialize its first product line, Xiphos. Its second product, CleanFUZE, is pending FDA approval and could go into clinical studies next year.
CleanFUZE is a spinal implant that time-releases antimicrobial silver ions to prevent infections.
Read the report on DiFusion Technologies.
Related Articles on Orthopedic Device Companies:
14 New Orthopedic and Spine Device Company Financial Reports
Orthopedic Device Company Nomcomed Plans $2.78M Expansion to Indiana Facility
Orthopedic Device Company CEOs Expect Market Growth in 2011
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
